Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3060-3068
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3060
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3060
Index | Time | Therapy group (n = 37) | Control group (n = 37) | t | P value |
T (ng/mL) | Before treatment | 0.56 ± 0.18 | 0.64 ± 0.24 | -1.622 | 0.109 |
After treatment | 0.39 ± 0.11 | 0.42 ± 0.12 | -1.121 | 0.266 | |
LH (mIU/mL) | Before treatment | 9.68 ± 2.31 | 10.70 ± 2.63 | -1.772 | 0.081 |
After treatment | 8.02 ± 1.82 | 9.44 ± 7.66 | -1.097 | 0.276 | |
FSH (mIU/mL) | Before treatment | 5.88 ± 1.22 | 6.46 ± 1.81 | -1.616 | 0.110 |
After treatment | 5.42 ± 1.36 | 5.84 ± 1.59 | -1.221 | 0.226 | |
LH/FSH | Before treatment | 1.80 ± 0.46 | 1.96 ± 0.58 | -1.315 | 0.193 |
After treatment | 1.48 ± 0.62 | 2.14 ± 0.77 | -4.061 | 0.000 |
- Citation: Liu R, Li M, Wang P, Yu M, Wang Z, Zhang GZ. Preventive online and offline health management intervention in polycystic ovary syndrome. World J Clin Cases 2022; 10(10): 3060-3068
- URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3060.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3060